IL113816A - Pharmaceutical preparations containing desogestral, their preparation and use - Google Patents

Pharmaceutical preparations containing desogestral, their preparation and use

Info

Publication number
IL113816A
IL113816A IL11381695A IL11381695A IL113816A IL 113816 A IL113816 A IL 113816A IL 11381695 A IL11381695 A IL 11381695A IL 11381695 A IL11381695 A IL 11381695A IL 113816 A IL113816 A IL 113816A
Authority
IL
Israel
Prior art keywords
desogestrel
solid
mixed
dissolved
optionally
Prior art date
Application number
IL11381695A
Other languages
English (en)
Hebrew (he)
Other versions
IL113816A0 (en
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8216929&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL113816(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of IL113816A0 publication Critical patent/IL113816A0/xx
Publication of IL113816A publication Critical patent/IL113816A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL11381695A 1994-06-08 1995-05-22 Pharmaceutical preparations containing desogestral, their preparation and use IL113816A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP94201625 1994-06-08

Publications (2)

Publication Number Publication Date
IL113816A0 IL113816A0 (en) 1995-08-31
IL113816A true IL113816A (en) 1998-12-06

Family

ID=8216929

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11381695A IL113816A (en) 1994-06-08 1995-05-22 Pharmaceutical preparations containing desogestral, their preparation and use

Country Status (19)

Country Link
US (1) US5709881A (da)
EP (1) EP0688565B2 (da)
JP (1) JP4302783B2 (da)
KR (1) KR100380841B1 (da)
CN (1) CN1057673C (da)
AT (1) ATE254921T1 (da)
AU (1) AU697512B2 (da)
BR (1) BR9502704A (da)
CA (1) CA2150642C (da)
DE (1) DE69532176T3 (da)
DK (1) DK0688565T4 (da)
ES (1) ES2210272T5 (da)
FI (1) FI952765A (da)
HK (1) HK1001996A1 (da)
HU (1) HU218282B (da)
IL (1) IL113816A (da)
NZ (1) NZ272285A (da)
PT (1) PT688565E (da)
RU (1) RU2160107C2 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2204613T3 (es) * 1999-04-06 2004-05-01 Akzo Nobel N.V. Androgenos 7-alfa alquilo oralmente activos.
EP1204410B1 (en) * 1999-07-30 2012-09-12 Capsugel Belgium NV Multi-component pharmaceutical dosage form
CN100579514C (zh) 2001-07-06 2010-01-13 生命周期药物公司 通过受控制的凝聚而制备颗粒物的方法以及提高生物利用度的方法
TW200403075A (en) * 2002-05-29 2004-03-01 Akzo Nobel Nv Progestagenic dosage units
CN105030792B (zh) * 2015-06-30 2017-08-25 上海交通大学 Desogestrel在制备抗结肠癌/ER阴性的Ah受体阳性的乳腺癌产品中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56140915A (en) † 1980-04-07 1981-11-04 Yamanouchi Pharmaceut Co Ltd Pharmaceutical preparation for solid drug
DE3421468A1 (de) * 1984-06-08 1985-12-19 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
EP0300523B1 (en) 1987-07-06 1991-08-14 Akzo N.V. Pharmaceutical dosage unit for the prevention or treatment of climacteric complaints
EP0368373A1 (en) * 1988-10-13 1990-05-16 Akzo Nobel N.V. Multi-phase contraceptive preparation
US4948593A (en) * 1989-05-15 1990-08-14 Alza Corporation Osmotic dosage form comprising an estrogen and a progestogen
US5395627A (en) † 1992-09-04 1995-03-07 Akzo N.V. Pharmaceutical granulate

Also Published As

Publication number Publication date
ES2210272T5 (es) 2008-05-01
KR960000231A (ko) 1996-01-25
PT688565E (pt) 2004-03-31
DK0688565T3 (da) 2004-03-29
HU218282B (en) 2000-07-28
RU2160107C2 (ru) 2000-12-10
IL113816A0 (en) 1995-08-31
AU697512B2 (en) 1998-10-08
US5709881A (en) 1998-01-20
FI952765A0 (fi) 1995-06-06
DK0688565T4 (da) 2008-03-17
FI952765A (fi) 1995-12-09
EP0688565B1 (en) 2003-11-26
KR100380841B1 (ko) 2003-08-14
ATE254921T1 (de) 2003-12-15
AU2053195A (en) 1995-12-14
EP0688565B2 (en) 2007-11-21
EP0688565A1 (en) 1995-12-27
BR9502704A (pt) 1996-03-05
JPH07330610A (ja) 1995-12-19
HK1001996A1 (en) 1998-07-24
HUT71491A (en) 1995-11-28
DE69532176D1 (de) 2004-01-08
HU9501654D0 (en) 1995-07-28
CN1122226A (zh) 1996-05-15
DE69532176T2 (de) 2004-08-12
DE69532176T3 (de) 2008-06-12
CA2150642A1 (en) 1995-12-09
ES2210272T3 (es) 2004-07-01
JP4302783B2 (ja) 2009-07-29
CN1057673C (zh) 2000-10-25
CA2150642C (en) 2008-04-22
NZ272285A (en) 1996-08-27

Similar Documents

Publication Publication Date Title
EP1980242B1 (en) Liquid compositions as a micro-emulsion pre-concentrate comprising drospirenone moleculary dispersed
JP3474210B2 (ja) 低用量乾燥医薬製剤
US5395627A (en) Pharmaceutical granulate
US6514958B1 (en) Stabilized tibolone compositions
US5709881A (en) Tablet capsule or granule comprising desogestrel
EP3854384A1 (en) Pharmaceutical formulation comprising abiraterone acetate
JP2914690B2 (ja) 安定なビタミンｄ▲下３▼類含有製剤
US20050181040A1 (en) Progestagenic dosage unit
KR100349230B1 (ko) 약제용과립및그제조방법

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees